Business Description
Atea Pharmaceuticals is a Boston-based company focused on developing oral medicines to treat serious viral infections. Its most advanced treatment combines two drugs, bemnifosbuvir and ruzasvir, currently in late-stage clinical trials for hepatitis C, while a separate drug for chronic hepatitis E is in earlier testing. The company works with MSD International GmbH to develop and bring ruzasvir to market.
